While we had very busy start in Q1 2025, let’s take a look back at what happened last year.
First, the tip of the iceberg. ORYL’s team was present at several conferences, seminars and tradeshows, gathering precious insights, customers feedbacks and secure new collaborations :
- Analytica
- 7th Basel Campus Seminar
- Swiss Biotech Day
- The Pharma Days
- Future Labs Live
- BOS Basel
- EFMC-ISMC
- ILMAC
- Drug Discovery London
- CPHi Europe
On the financing side, we closed successfully our seed round early in 2024. We also received an EIC Transition grant of € 2.5 M with a consortium of key partners: FHNW, ALPhANOV, EU-Openscreen ERIC. Work started in June, and will go through until end of 2026.
In October, we moved office from EPFL to Biopôle in Lausanne.
Finally, behind the scenes, we achieved important milestones for the development of our instrument. More news coming soon on that topic!
This is also the occasion to thank all the people who trusted us and helped us going forward. Let’s reach new heights together in 2025!